You're reading the free version. Trader adds the live tape and alerts.
Start tracking
JSPR Buy Disclosure
Ros Matthew E · SEC Form 4 · Filed Jul 22, 2026
Buy
Reported value range
Not reported
Ros Matthew E Chief Operating Officer
JSPR
Jasper Therapeutics
JSPR
Transaction date
Jul 20, 2026
Public filing date
Jul 22, 2026
Filing lag
Filed 2 days later
JSPR daily price context
Close on/before transaction
$0.81
Jul 20, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Non-Voting Convertible Preferred Stock on Voting Common Stock
- Quantity / price
- 881 shares
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001213900-26-080525
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
Not reported
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Jasper Therapeutics, Inc. JSPR Current | Buy | Jul 20, 2026 | Not reported |